Kloepfel MagazinKloepfel Magazin
    Top Article

    Preface

    8. September 2023

    Forbes World´s Best Management Consulting Firms 2023

    8. September 2023

    New headquarter of Kloepfel (EPSA Group) in Düsseldorf

    8. September 2023
    Facebook Twitter Instagram
    • Kloepfel Group
    • Kloepfel Consulting
    • Kloepfel Karriere
    LinkedIn Twitter Facebook Instagram YouTube
    Kloepfel MagazinKloepfel Magazin
    • START
    • NEWS
      • HWWI
      • INTERVIEWS
      • CAREER
      • KLOEPFEL GROUP
      • WHITEPAPER
      • SURVEY
      • INDUSTRY NEWS
        • ENGINEERING
        • LOGISTICS
        • SUPPLY CHAIN
    • NEWSLETTER
    • CONTACT
      • IMPRINT
      • PRIVACY POLICY
    Kloepfel MagazinKloepfel Magazin
    Home»Industry News»Supply Chain»AI-based drug discovery
    Supply Chain

    AI-based drug discovery

    By Kloepfel9. January 2023Updated:19. January 20232 Mins Read
    LinkedIn Facebook WhatsApp Email
    Share
    LinkedIn Facebook Twitter WhatsApp Email

    Biontech plans to acquire Instadeep

    Biontech intends to acquire technology company Instadeep. The conclusion of an agreement to this effect was announced by both companies last week.

    Instadeep is an artificial intelligence (AI) and machine learning (ML) company. It says it is a leader in AI-based decision-making systems.

    Biontech made an initial equity investment in Instadeep back in January 2022. Now the Mainz-based immunotherapy company plans to acquire the remaining shares in Instadeep. The current transaction includes an upfront payment of approximately 362 million British pounds in cash and Biontech shares, according to Biontech. In addition, Instadeep’s shareholders are eligible to receive additional performance-based payments of up to approximately 200 million British pounds, Biontech reports. The two companies expect the transaction to close in the first half of 2023.

    Services also for logistics

    Instadeep is then to operate globally as a subsidiary of Biontech and retain its headquarters in London. The UK company will become the core of a growing portfolio of initiatives around AI and ML at Biontech, he said. In doing so, Instadeep is expected to not only execute projects for Biontech, but also continue to provide services to clients in various industries around the world, including technology, transportation and logistics, industrial and financial services.

    Biontech’s strategy

    As Biontech explains, the acquisition is part of its strategy to build world-leading capabilities in AI-driven drug discovery and the development of next-generation immunotherapies and vaccines.

    The transaction is expected to add approximately 240 professionals to Biontech’s workforce, including teams in AI, ML, bioengineering, data science, and software development.

    Collaboration since 2019

    The two companies have been working together since 2019. For example, Biontech said it has jointly developed several AI-based end-to-end applications trained on public and proprietary datasets in a variety of scientific fields.

    Growing importance of artificial intelligence (AI).

    CEO and co-founder of Instadeep, Karim Beguir says, “AI is evolving exponentially. Our mission at InstaDeep has always been to make sure everyone can benefit from it.”

    Together, he says, they aim to build a world-leading company that combines biopharmaceutical research and artificial intelligence.

    Source: www.kloepfel-consulting.com

    Next article: Sustainability of great importance for transport companies
    Previous article
    Share. LinkedIn Facebook Twitter WhatsApp Email

    Related Posts

    BMW Group is constructing a logistics hall for high-voltage batteries

    8. September 2023

    Amazon opens logistics center with 3,000 robots

    8. September 2023

    Dual-Sourcing und Nearshoring in the automotive industry in focus

    8. September 2023

    Ocean Shipping Index improves

    4. August 2023

    Import prices down again

    4. August 2023

    thyssenkrupp Steel launches “tkH2Steel” decarbonization project

    4. August 2023

    Comments are closed.

    Top Artikel

    Preface

    By Kloepfel8. September 2023

    September issue Kloepfel Magazine Dear Readers, Liquidity is a top priority. To ensure this, working…

    Forbes World´s Best Management Consulting Firms 2023

    8. September 2023

    New headquarter of Kloepfel (EPSA Group) in Düsseldorf

    8. September 2023

    Liquidity squeeze? Working capital management explained simply!

    8. September 2023

    Receivables management and liabilities

    8. September 2023
    Stay In Touch
    • Facebook
    • Twitter
    • Instagram
    • LinkedIn
    About us
    About us

    Das Magazin für den effektiveren Einkauf!

    Kloepfel Consulting GmbH
    Cecilienallee 6-7
    40474 Düsseldorf

    Telefon: +49 211 941 984 33
    E-Mail: info@kloepfel-consulting.com

    New Article

    Preface

    8. September 2023

    Forbes World´s Best Management Consulting Firms 2023

    8. September 2023

    New headquarter of Kloepfel (EPSA Group) in Düsseldorf

    8. September 2023
    © 2023 Kloepfel Consulting GmbH All rights reserved
    • Home
    • News
    • Contact
    • Imprint
    • Privacy Policy

    Type above and press Enter to search. Press Esc to cancel.